Franklin Resources’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Franklin Resources’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,492,368	Closed	-$17M	–	2994
2023 Q4	$17M	Buy	1,492,368 +1,360,041	+1,028%	+$10.7M	0.01%	793
2023 Q3	$533K	Sell	132,327 -2	-0%	-$15	﹤0.01%	1886
2023 Q2	$940K	Hold	132,329	–	–	﹤0.01%	1669
2023 Q1	$985K	Hold	132,329	–	–	﹤0.01%	1509
2022 Q4	$960K	Sell	132,329 -121	-0.1%	-$1.02K	﹤0.01%	1526
2022 Q3	$1.28M	Hold	132,450	–	–	﹤0.01%	1457
2022 Q2	$2.53M	Sell	132,450 -33,865	-20%	-$877K	﹤0.01%	1289
2022 Q1	$8.27M	Buy	166,315 +45,114	+37%	+$2.34M	﹤0.01%	1059
2021 Q4	$9.15M	Buy	121,201 +8,026	+7%	+$548K	﹤0.01%	1089
2021 Q3	$8.94M	Sell	113,175 -576	-0.5%	-$57.9K	﹤0.01%	1085
2021 Q2	$15.8M	Buy	113,751 +6,297	+6%	+$1.2M	0.01%	920
2021 Q1	$22.5M	Buy	+107,454	New	+$21.5M	0.01%	811

Franklin Resources's HARP Position: Q1 2024 in Review

Franklin Resources sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 1,492,368 shares — an estimated $17M sold.

Franklin Resources first reported a position in HARP in Q1 2021 and held it in 12 quarters. The position peaked at $22.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Franklin Resources reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Franklin Resources sold 1,492,368 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $17M.
Franklin Resources first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
Franklin Resources's Harpoon Therapeutics, Inc. Common Stock position peaked at $22.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.